Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
Today is World Rare Disease Day 2018. At FDNA, we recognize that one day is simply not enough time to raise awareness for the plight of rare and undiagnosed patients. Their diseases impact their lives and the lives of their families every day. Their symptoms, their struggles, their fight for more awareness–both socially and in […]
English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced the launch of the Genomics Collaborative. This initiative prompts clinicians, patients, advocates and researchers to join forces in an effort to accelerate breakthroughs in precision medicine. The Genomics Collaborative allows participants to access FDNA’s deep […]
The National Institutes of Health (NIH) recently launched a program to accelerate the transition of genome editing into clinical applications. Over the next six years, this Somatic Cell Genome Editing program aims to award $190 million to researchers for projects focused on creating and improving gene editing tools and delivery systems, testing the efficacy and […]
At FDNA, we’re making precision medicine a reality by crowdsourcing knowledge and integrating next-generation phenotyping (NGP) technologies into every patient evaluation. NGP is the computational capture, analysis and integration of phenotypic data into health analysis—a hallmark of FDNA’s technologies. In 2017, our Face2Gene application turned five, and alongside our collaborators, we marked some serious milestones: […]
In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only effective for 30-50% of patients. The reason? A “one-size-fits-all” approach to pharmaceutical development and commercialization. At this year’s 22nd Annual Drug Delivery Partnership meeting, a new approach to the pharma value chain is in discussion. […]
Boston-based health and tech start-up calls on patients and clinicians to share their stories to help make new discoveries needed to diagnose and treat rare genetic diseases. Beginning in March, the 2017 Year of Discovery initiative was created to unite clinicians, labs and patients worldwide to make rare disease discoveries, with a special focus on […]
December Discoveries – Skin Disorders As part of FDNA’s Year of Discovery, FDNA collaborated with the National Foundation for Ectodermal Dysplasias, sponsored by GeneDx, to research and promote awareness of Skin Disorders throughout the month of December. About Skin Disorders Abnormalities of the hair, skin, sweat glands, nails, and teeth are frequently associated with various […]
Photo from the National Foundation for Ectodermal Dysplasias (NFED) website. FDNA focused on skin disorders in December for the Year of Discovery. We are uniting healthcare, advocacy, and technology for rare disease advancements. Every time a case is analyzed by Face2Gene, the de-identified case data can train the system to recognize new phenotypes, facial characteristics and genes. […]
Genetic sequencing is becoming a more popular diagnostic tool; however, even with all the advancements, it only reaches a diagnosis for 1 of 4 patients. Listen to GeneDx’s Kyle Retterer and FDNA’s Dekel Gelbman discuss how next-generation phenotyping (NGP) technology/precision phenomics is making way for a new era in precision medicine, driving up genetic testing […]